← All stocks

KALA BIO, Inc.

KALA Net buying
CIK 0001479419 #5116 in the set updated 22 Sep 2026
Bought (120 mo)
$211.97M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$4.19M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$4.19M
79 of 79 sales
Net
+$207.79M
+$207.79M against sales at will

By person

23 insiders · 130 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Shah Rajeev M.
Director
$78.00M (3)
+$78.00M
23,902,462
$19.60M
+84.0%
RA CAPITAL MANAGEMENT, L.P. entity
10% owner
$78.00M (3)
$1.85M (4)
+$76.15M
28,508,993
$23.38M
+44.1%
Grunberg Gregory
Director
$28.22M (3)
+$28.22M
5,451,860
$4.47M
ORBIMED ADVISORS LLC entity
10% owner
$19.22M (15)
+$19.22M
3,447,840
$2.83M
+4,381%
CDK ASSOCIATES, L.L.C. entity
10% owner
$3.23M (1)
+$3.23M
215,000
$176.30K
Longitude Capital Partners II, LLC entity
10% owner
$3.23M (1)
+$3.23M
2,270,946
$1.86M
BAKER BROS. ADVISORS LP entity
Former 10% owner
$2.00M (2)
$1.06M (4)
+$943.28K
425,006
$348.50K
−49.7%
Iwicki Mark T
Director
$528.93K (13)
−$528.93K
103,540
$84.90K
Brazzell Romulus K
SEE REMARKS
$191.44K (13)
−$191.44K
35,952
$29.48K
Reumuth Mary
CHIEF FINANCIAL OFFICER
$143.50K (14)
−$143.50K
28,906
$23.70K
Bazemore Todd
Director
$57.83K (3)
$176.30K (13)
−$118.46K
35,974
$29.50K
Chen Hongming
CHIEF SCIENTIFIC OFFICER
$100.32K (4)
−$100.32K
204,515
$167.70K
+343.8%
Kharabi Darius
CHIEF BUSINESS OFFICER
$88.74K (7)
−$88.74K
41,760
$34.24K
Trachtenberg Eric
SEE REMARKS
$47.08K (7)
−$47.08K
68,066
$55.81K
Rosen Howard B
Director
$27.10K (1)
+$27.10K
24,480
$20.07K
TEPPER ROBERT I
Director
1,621,092
$1.33M
Paull Robert Bradley
Director
1,247,298
$1.02M
Hadley Harbor Master Investors (Cayman) L.P.
10% owner
846,566
$694.18K
KOVEN ANDREW I
Director
16,972
$13.92K
Blumenkranz Mark S.
Director
14,367
$11.78K
PERRY GREGORY D
Director
13,344
$10.94K
Myers C. Daniel
Director
10,374
$8.51K
Farid Marjan
Director
10,242
$8.40K

No percentages here. This company's share count has moved by a factor of 201.6 over the window, from 4,610,139 to 929,491,578 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 242
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 17
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 79
Transactions with no price 0
Shares from compensation/vesting 23,538,658
Sales filed before the plan box existed 38
History held since 20 Jul 2017